Companies: 10,795·Total market cap: $144.5T
Living Cell Technologies Limited

Living Cell Technologies Limited

LVCLYOTCHealthcare
$0.03
+$0.01(+24.39%)
Market Cap$11392472
P/E Ratio
52W High$0.08
52W Low$0.02

Living Cell Technologies Limited (LVCLY) Revenue

Annual & quarterly revenue history · segment & region breakdown

LVCLY · revenue · updated Jun 10, 2026

Core revenue metrics

Living Cell Technologies Limited trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
250.82×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$1K
48 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Living Cell Technologies Limited SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
LVCLY revenue by year · LVCLY revenue history · LVCLY annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Living Cell Technologies Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Living Cell Technologies Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Living Cell Technologies Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

LVCLY revenue · 4 questions

LVCLY's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

LVCLY revenueLVCLY annual revenuewhat is LVCLY revenueLVCLY TTM revenue

Source: FMP · Living Cell Technologies Limited SEC filings · GAAP · Living Cell Technologies Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026